269 related articles for article (PubMed ID: 19584052)
1. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.
Kuronuma K; Mitsuzawa H; Takeda K; Nishitani C; Chan ED; Kuroki Y; Nakamura M; Voelker DR
J Biol Chem; 2009 Sep; 284(38):25488-500. PubMed ID: 19584052
[TBL] [Abstract][Full Text] [Related]
2. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
Erridge C; Kennedy S; Spickett CM; Webb DJ
J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
[TBL] [Abstract][Full Text] [Related]
3. Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation.
Viviano CJ; Bakewell WE; Dixon D; Dethloff LA; Hook GE
Biochim Biophys Acta; 1995 Dec; 1259(3):235-44. PubMed ID: 8541330
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.
Sano H; Sohma H; Muta T; Nomura S; Voelker DR; Kuroki Y
J Immunol; 1999 Jul; 163(1):387-95. PubMed ID: 10384140
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
Stamme C; Müller M; Hamann L; Gutsmann T; Seydel U
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898
[TBL] [Abstract][Full Text] [Related]
6. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2.
Murakami S; Iwaki D; Mitsuzawa H; Sano H; Takahashi H; Voelker DR; Akino T; Kuroki Y
J Biol Chem; 2002 Mar; 277(9):6830-7. PubMed ID: 11724772
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages.
Miles PR; Bowman L; Rao KM; Baatz JE; Huffman L
Am J Physiol; 1999 Jan; 276(1):L186-96. PubMed ID: 9887071
[TBL] [Abstract][Full Text] [Related]
8. Effect of surfactant protein A (SP-A) on the production of cytokines by human pulmonary macrophages.
Arias-Diaz J; Garcia-Verdugo I; Casals C; Sanchez-Rico N; Vara E; Balibrea JL
Shock; 2000 Sep; 14(3):300-6. PubMed ID: 11028547
[TBL] [Abstract][Full Text] [Related]
9. Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages.
Stamme C; Walsh E; Wright JR
Am J Respir Cell Mol Biol; 2000 Dec; 23(6):772-9. PubMed ID: 11104730
[TBL] [Abstract][Full Text] [Related]
10. The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids.
Numata M; Kandasamy P; Voelker DR
Immunol Rev; 2023 Aug; 317(1):166-186. PubMed ID: 37144896
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors.
Yamazoe M; Nishitani C; Takahashi M; Katoh T; Ariki S; Shimizu T; Mitsuzawa H; Sawada K; Voelker DR; Takahashi H; Kuroki Y
J Biol Chem; 2008 Dec; 283(51):35878-88. PubMed ID: 18990700
[TBL] [Abstract][Full Text] [Related]
12. Mite allergen induces nitric oxide production in alveolar macrophage cell lines via CD14/toll-like receptor 4, and is inhibited by surfactant protein D.
Liu CF; Chen YL; Chang WT; Shieh CC; Yu CK; Reid KB; Wang JY
Clin Exp Allergy; 2005 Dec; 35(12):1615-24. PubMed ID: 16393328
[TBL] [Abstract][Full Text] [Related]
13. Purification of a cell-surface receptor for surfactant protein A.
Chroneos ZC; Abdolrasulnia R; Whitsett JA; Rice WR; Shepherd VL
J Biol Chem; 1996 Jul; 271(27):16375-83. PubMed ID: 8663107
[TBL] [Abstract][Full Text] [Related]
14. Myeloid differentiation protein 2 silencing decreases LPS-induced cytokine production and TLR4/MyD88 pathway activity in alveolar macrophages.
Ren W; Hu L; Hua F; Jin J; Wang Y; Zhu L
Immunol Lett; 2011 Dec; 141(1):94-101. PubMed ID: 21849156
[TBL] [Abstract][Full Text] [Related]
15. Modulation of nitric oxide production by lung surfactant in alveolar macrophages.
Kalina M; Blau H; Riklis S; Hoffman V
Adv Exp Med Biol; 2000; 479():37-48. PubMed ID: 10897408
[No Abstract] [Full Text] [Related]
16. Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.
Numata M; Voelker DR
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159139. PubMed ID: 35240310
[TBL] [Abstract][Full Text] [Related]
17. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways.
Joh EH; Gu W; Kim DH
Biochem Pharmacol; 2012 Aug; 84(3):331-40. PubMed ID: 22564908
[TBL] [Abstract][Full Text] [Related]
18. Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway
Hsieh WT; Hsu MH; Lin WJ; Xiao YC; Lyu PC; Liu YC; Lin WY; Kuo YH; Chung JG
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204506
[TBL] [Abstract][Full Text] [Related]
19. [Effect of L-arginine on pulmonary surfactant and alveolar macrophages in rats with pulmonary injury induced by lipopolysaccharide].
Li LP; Zhang JX; Li LF; Xie LJ; Zhang QZ; Hao N; Li GF
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 May; 28(3):263-6. PubMed ID: 22860431
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages.
Kandasamy P; Zarini S; Chan ED; Leslie CC; Murphy RC; Voelker DR
J Biol Chem; 2011 Mar; 286(10):7841-7853. PubMed ID: 21205826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
